Trials (European Institute of Oncology): Revision history

15 December 2025

• curprev 11:1411:14, 15 December 2025‎ Francine talk contribs‎ 120,479 bytes +270‎ No edit summary undo

6 December 2025

• curprev 12:4112:41, 6 December 2025‎ Lucas talk contribs‎ m 120,209 bytes +1,701‎ Update categories. undo

4 December 2025

• curprev 00:0000:00, 4 December 2025‎ Larysse talk contribs‎ 118,508 bytes +47‎ No edit summary undo

2 December 2025

• curprev 13:5813:58, 2 December 2025‎ Lucas talk contribs‎ m 118,461 bytes +90‎ Update categories. undo

4 December 2023

• curprev 16:0616:06, 4 December 2023‎ Francine talk contribs‎ 118,371 bytes +118,371‎ Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to European Institute of Oncology page '''NCTID''': NCT05554003 '''Title''': Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study '''Study Summary''': Study design and rationale: Neuroendocrine neoplasms (NENs ) represent a heterogeneous group of malignancies, which differ in terms of behavio r and prognosis. M..."